The β‐sulfonyl nitrile compound OLT1177 also was shown to inhibit NLRP3‐mediated IL‐1β release from stimulated PBMCs of CAPS patients and primary human neutrophils (Figure 3).130. Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.